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Background
Human immunodeficiency virus (HIV)-induced immune
activation of B cells is thought to be a contributing fac-
tor to the increased frequency of B-cell malignancies
observed in HIV-infected individuals. In some cases, as
in Burkitt lymphoma, tumors arise before profound
immunosuppression occurs, when the CD4
+ cell count
is still high. Therefore, immunodeficiency per se may
not be necessary for lymphomagenesis in these patients,
and that HIV itself may have an oncogenic potential.
There are no clear answers to explain how HIV leads
to malignant transformation, even though several events
have been proposed as co-factors in HIV-related tumori-
genesis. In particular, the HIV-encoded Tat protein is
thought to participate in B-cell abnormalities observed
in vivo, as it can be released from the HIV-infected cells
and then lead to differential modulation of naïve, mem-
ory and germinal center B-cells.
Recent findings indicate a complex interplay between
viral proteins and host transcription regulatory machi-
neries, including histone deacetylases (HDACs), histone
acetyltransferases (HATs), histone metyltransferases
(HMTs) and DNA metyltransferases (DNMTs). Tat can
bind to histone acetyltransferases (HATs) p300/CBP,
p300/CBP-associated factor, and hGN5. Chromatin
remodelling may therefore represent a mechanism of
control of gene expression, whose deregulation may
eventually lead to malignant transformation.
Methods
GEP and microRNA profiles were obtained in HIV+ pri-
mary tumors.
Results
We investigated the expression of several chromatin
remodelers, both in human cell lines, either transfected
or not with Tat, and HIV-positive vs. HIV-negative pri-
mary tumors. Gene expression analysis revealed a differ-
ential expression of genes involved in chromatin
remodelling between HIV-positive and HIV-negative
patients. In particular, we observed a modulation of spe-
cific acetyltransferases and DNA metyltransferases,
which seem to be regulated at the post-transcriptional
level.
We then analyzed the expression of microRNAs (miR-
NAs) predicted to have specific chromatin remodelers
as targets, and we observed that these miRNAs resulted
significantly down-regulated in HIV-positive subjects.
Discussion
These findings lead to the hypothesis that HIV may
interfere with physiological regulation of cell functions
maintained by miRNAs, may be through viral-encoded
miRNAs. We are currently analyzing which genetic/epi-
genetic mechanism underlies HIV-mediated miRNA
silencing in host cells.
Collectively, our results support the possible onco-
genic role of HIV and open new scenarios in the identi-
fication of novel therapeutic targets in HIV-related
malignancies.
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